Evidence map›Paper›PMID 35520921›Full record

ArticleRSC advances2019

Total synthesis of pyrano[3,2-

Tomoki Itoh, Yuusuke Chiba, Shunsuke Kawaguchi, Yuki Koitaya, Yuuma Yoneta, Koji Yamada, Takumi Abe

Abstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. An Oxidant-Free and Mild Strategy for Quinazolin-4(3Molecules (Basel, Switzerland) · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tomoki ItohFaculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido Ishikari-tobetsu Hokkaido 0610293 Japan abe-t@hoku-iryo-u.ac.jp.
Yuusuke ChibaFaculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido Ishikari-tobetsu Hokkaido 0610293 Japan abe-t@hoku-iryo-u.ac.jp.
Shunsuke KawaguchiFaculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido Ishikari-tobetsu Hokkaido 0610293 Japan abe-t@hoku-iryo-u.ac.jp.
Yuki KoitayaFaculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido Ishikari-tobetsu Hokkaido 0610293 Japan abe-t@hoku-iryo-u.ac.jp.
Yuuma YonetaFaculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido Ishikari-tobetsu Hokkaido 0610293 Japan abe-t@hoku-iryo-u.ac.jp.
Koji YamadaFaculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido Ishikari-tobetsu Hokkaido 0610293 Japan abe-t@hoku-iryo-u.ac.jp.
Takumi AbeFaculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido Ishikari-tobetsu Hokkaido 0610293 Japan abe-t@hoku-iryo-u.ac.jp.ORCID https://orcid.org/0000-0003-1729-1097

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The regioselective synthesis of pyrano[3,2-

Identifiers

PMID35520921
PMCPMC9062488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.